NeoPhore closes oversubscribed Series B extension round with additional funding from Bristol Myers Squibb

Additional funding will be used to explore novel biology around the MMR pathway and accelerate progression of the lead program into candidate selectionView original content:https://www.prnewswire.co.uk/news-releases/neophore-closes-oversubscribed-series-b-extension-round-with-additional-funding-from-bristol-myers-squibb-302151962.html

en | US1101221083 | NEOPHORE | boerse | 67929587 |